Evidence map›Paper›PMID 33182751›Full record

ReviewMolecules (Basel, Switzerland)2020

Design of Photosensitizing Agents for Targeted Antimicrobial Photodynamic Therapy.

Maxime Klausen, Muhammed Ucuncu, Mark Bradley

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
12.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 189 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. First evidence of photoinactivation of rapidly growing mycobacteria by tetra-cationic porphyrins with peripheral cisplatin.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2025
    Article
  9. RuvidarViruses · 2025
    Article
  10. Review
  11. Article
  12. Antimicrobial photodynamic activity of a BODIPY on an alternative preclinical model Galleria mellonella.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2025
    Article
  13. Mesoporous FeAdvanced healthcare materials · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Maxime KlausenSchool of Chemistry and the EPSRC IRC Proteus, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh EH9 3FJ, UK.ORCID 0000-0003-0805-9886
Muhammed UcuncuSchool of Chemistry and the EPSRC IRC Proteus, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh EH9 3FJ, UK.ORCID 0000-0001-6200-9340
Mark BradleySchool of Chemistry and the EPSRC IRC Proteus, University of Edinburgh, Joseph Black Building, David Brewster Road, Edinburgh EH9 3FJ, UK.
Engineering and Physical Sciences Research Council · GB

Funding

Engineering and Physical Sciences Research Council EP/R005257/1Engineering and Physical Sciences Research Council EP/R018669/1
6 · The paper itself

Abstract

Photodynamic inactivation of microorganisms has gained substantial attention due to its unique mode of action, in which pathogens are unable to generate resistance, and due to the fact that it can be applied in a minimally invasive manner. In photodynamic therapy (PDT), a non-toxic photosensitizer (PS) is activated by a specific wavelength of light and generates highly cytotoxic reactive oxygen species (ROS) such as superoxide (O

Indexed as

AnimalsAnti-Infective AgentsHumansHydrogen-Ion ConcentrationLiposomesMiceMicellesOligosaccharidesPeptidesPhotochemotherapyPhotosensitizing AgentsPolymersSinglet OxygenStatic ElectricitySuperoxidesAnti-Infective AgentsLiposomesMicellesOligosaccharidesPeptidesPhotosensitizing AgentsPolymersSinglet OxygenSuperoxidesantimicrobial peptidesantimicrobial resistancenanomaterialsphotodynamic therapyphotosensitizerreactive oxygen species

Identifiers

PMID33182751
PMCPMC7696090
OpenAlexW3103000887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.